← All Xenetic Biosciences, INC filings

Xenetic Biosciences, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
XBIO
Xenetic Biosciences, INC
DEFA14A: Xenetic Biosciences Adjourns Annual Meeting
Xenetic Biosciences, Inc. announced the adjournment of its 2025 Annual Meeting of Stockholders due to a lack of quorum, rescheduling it for January 8, 2026.
NASDAQ
XBIO
Xenetic Biosciences, INC
DEFA14A: Xenetic BioSciences Sets Annual Meeting for Dec 11
Xenetic BioSciences, Inc. announced its 2024 Annual Meeting of Stockholders will be held virtually on December 11, 2024, to vote on director elections, auditor ratification, and executive compensation.
NASDAQ
XBIO
Xenetic Biosciences, INC
DEF: Xenetic Biosciences Sets 2025 Annual Meeting Agenda
Xenetic Biosciences, Inc. announces its 2025 Annual Meeting of Stockholders to address director elections, auditor ratification, and executive compensation.
NASDAQ
XBIO
Xenetic Biosciences, INC
DEFA14A: Xenetic Biosciences Sets Date for Annual Stockholder Meeting, Outlines Voting Proposals
Xenetic Biosciences announces its annual stockholder meeting to be held on December 11, 2024, outlining key proposals for voting, including the election of directors and ratification of the company's accounting firm.
NASDAQ
XBIO
Xenetic Biosciences, INC
DEF 14A: Xenetic Biosciences Sets Date for Annual Stockholders Meeting, Outlines Key Proposals
Xenetic Biosciences announces its annual meeting of stockholders to be held virtually on December 11, 2024, featuring proposals including director elections, auditor ratification, and executive compensation votes.